Romano Drugs Private Limited

Romano Drugs Private Limited - pharma in Gandhinagar, Gujarat, India. FY 2026 financials & compliance.
CIN U24231GJ1996PTC030650 Incorporated 06 September 1996 ROC Ahmedabad HQ Gandhinagar, Gujarat, India
Active Private Limited Company pharma MSME · Small
Revenue · FY 2025
₹21,568
▼ 100% YoY
Net loss · FY 2025
₹99.37 Lakh
Latest filing
EBITDA · FY 2025
-₹51 Lakh
Latest filing
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹22.2 Lakh
Issued & subscribed
Open charges
₹1.57 Cr
Satisfied ₹2.6 Cr
Company age
30 yrs
Est. 1996
Directors on board
5
As per MCA filings

About Romano Drugs Private Limited

Data last updated:

Romano Drugs Private Limited is a private limited company based in Gandhinagar, Gujarat, India. It operates in the API manufacturers segment of the pharmaceuticals sector. It was incorporated on 06 September 1996 and has been in existence for over 30 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ1996PTC030650. Its GSTIN is 24AAACR9722P1ZX (Gujarat).

The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹22.2 Lakh. It is led by directors including Swati Shrikant Deshpande and Shrikant Shankarrao Deshpande.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 9/B Trimul Estate Nr. Lincoin Pharma Po.: Khatraj Ta. Kalol, Gandhinagar, Gujarat, India – 382721.

As per the financials filed for FY 2025, the company reported a revenue of ₹21,568, a decline of 100% compared to the previous year. For the same year it recorded a net loss of ₹99.37 Lakh and EBITDA of -₹51 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 93% over three years and 68% over five years.

As per MCA filings, the company has open charges of ₹1.57 Cr and satisfied charges of ₹2.6 Cr on record. Court records list 5 cases involving the company, including 5 filed against it.

Romano Drugs Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-09-0001532). The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24231GJ1996PTC030650
Registration Number 030650
Incorporation Date 06 September 1996
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant
MSME Classification Small
Udyam Registration UDYAM-GJ-09-0001532

Recognitions & Rankings of Romano Drugs

MSME (Udyam registered) Ministry of MSME
Category
Small (2024-25)
Udyam number
UDYAM-GJ-09-0001532

Contact details

Romano Drugs Private Limited's registered office is in Gandhinagar, Gujarat. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    9/B Trimul Estate Nr. Lincoin Pharma Po.: Khatraj Ta. Kalol, Gandhinagar, Gujarat, India – 382721
  • Industry
    Pharma, API Manufacturers

To see the full contact details of Romano Drugs Private Limited, buy the company report.

Comprehensive company report
Romano Drugs Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Business activity

The main business activity of Romano Drugs is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.

Main activity group codeMain activityBusiness activity codeBusiness activityShare of turnover
CManufacturingC6Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products

To see the full business activity and turnover split of Romano Drugs Private Limited, buy the company report.

Financials of Romano Drugs Private Limited

FY 2025 filings available

Romano Drugs Private Limited reported revenue of ₹21,568 (down 100% YoY) for FY 2025.

Revenue · FY 2025
₹21,568 ▼ 100%
Net loss · FY 2025
₹99.37 Lakh
EBITDA · FY 2025
-₹51 Lakh

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
3 years · compounded
▼ 93%
5 years · compounded
▼ 68%
EBITDA CAGR growth
1 year
▼ 41%
3 years · compounded
▼ 32%
5 years · compounded
▼ 26%

Revenue has declined at a compounded annual rate (CAGR) of 68% over five years. EBITDA fell 41% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA-₹51 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)-₹99.37 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin
Net Profit Margin
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Romano Drugs Private Limited, buy the company report.

Board of directors of Romano Drugs Private Limited

Romano Drugs has 5 current directors and 9 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Swati Shrikant DeshpandeDirector05 Jun 20233 Years 5 MonthsCurrent
Shrikant Shankarrao DeshpandeDirector06 Sep 199630 Years 2 MonthsCurrent
Rai Adarsh DaneshDirector03 Jul 20251 Years 4 MonthsCurrent
Mohit ChhajedAdditional Director05 Feb 20242 Years 9 MonthsCurrent
Avinash Tukaram SanasDirector05 Feb 20242 Years 9 MonthsCurrent

Auditor

Romano Drugs Private Limited is audited by BATHIYA & ASSOCIATES LLP for the financial year 2022.

Auditor firmFinancial yearFirm registration number
BATHIYA & ASSOCIATES LLPFY 2022101046W/W100063

Shareholding

The shareholding of Romano Drugs Private Limited is on record for 5 financial years, the latest being FY 2021, split between promoters, domestic institutions, foreign institutions, public shareholders and others.

Shareholder categoryFY 2021FY 2020FY 2019FY 2018FY 2017
Promoters
Domestic institutional investors (DII)
Foreign institutional investors (FII)
Public
Others

To see the full shareholding pattern of Romano Drugs Private Limited, buy the company report.

Charges & borrowings

Open charges
₹1.57 Cr
Satisfied charges
₹2.6 Cr
Breakdown by lending institutions
Others₹1.57 Cr
Punjab National Bank₹0.80 Cr
Gujarat State Financial Corporation₹0.23 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
30 Sep 2023100794557Others₹1.57 CrSatisfied
07 Aug 201210378662Punjab National Bank₹80 LakhSatisfied
17 Nov 199890104804Gujarat State Financial Corporation₹23 LakhSatisfied

To see the full charge records of Romano Drugs Private Limited, buy the company report.

Total charge records: 3 View all charges

MSME payment delays

Romano Drugs Private Limited has 6 MSME Form 1 returns on record between 2019 and 2023, listing 24 overdue payments to 14 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.

Suppliers with reported dues (5 of 14)

SupplierAmount dueDue sinceReported on
an individual supplier
Alcon Biosciences Private Limited
an individual supplier
an individual supplier
Parishil Laboratories Private Limited

To see the full MSME payment records of Romano Drugs Private Limited, buy the company report.

Individuals and sole proprietors among the suppliers are not named.

GST

Romano Drugs has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AAACR9722P1ZXGujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Romano Drugs Private Limited, buy the company report.

Recent activity

Romano Drugs Private Limited has 14 board changes on record since 1996: 5 appointments and 9 cessations. The latest: Rai Adarsh Danesh ceased to be Additional Director on 29 Sep 2025.

AGM
Romano Drugs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Rai Adarsh Danesh ceased to be Additional Director.
Charges
A charge registered on 30 Sep 2023 via Charge ID 100794557 with Others was fully satisfied on 30 Aug 2025.
Ceased
Shrikant Shankarrao Deshpande ceased to be Director.
Appointed
Rai Adarsh Danesh was appointed as Director.
Filing
Romano Drugs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Ceased
Avinash Tukaram Sanas ceased to be Additional Director.
Ceased
Mohit Chhajed ceased to be Additional Director.
Appointed
Avinash Tukaram Sanas was appointed as Director.
Appointed
Mohit Chhajed was appointed as Additional Director.
Charges
A charge with Others amounted to Rs. 157.00 Lakh with Charge ID 100794557 was registered on 30 Sep 2023.
Ceased
Kashyap Kirtikumar Patel ceased to be Director.

11 earlier events are in the company report.

Frequently asked questions

Romano Drugs is an active private limited company based in Gandhinagar, Gujarat, India. The company works in api manufacturers, within the pharma industry. It was incorporated on 06 September 1996 (30+ years old) and is registered under CIN U24231GJ1996PTC030650.

Romano Drugs has 5 current directors:

The latest financial statements of Romano Drugs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Romano Drugs is 24AAACR9722P1ZX, registered in Gujarat.

The CIN (Corporate Identification Number) of Romano Drugs is U24231GJ1996PTC030650. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Romano Drugs has 5 court cases on record: 5 filed against it.

Romano Drugs was incorporated on 06 September 1996, making it 30+ years old. It is registered with the Registrar of Companies, Ahmedabad.

Rai Adarsh Danesh ceased to be Additional Director on 29 Sep 2025. Shrikant Shankarrao Deshpande ceased to be Director on 21 Jul 2025. Rai Adarsh Danesh was appointed as Director on 03 Jul 2025. Romano Drugs has 14 board changes on record in total.

Yes, Romano Drugs is registered as a small enterprise under Udyam registration (number: UDYAM-GJ-09-0001532).

Romano Drugs has 6 MSME Form 1 returns on record between 2019 and 2023, listing 24 overdue payments to 14 micro and small suppliers. The latest return was filed on 29 Apr 2023.

The registered office of Romano Drugs is at 9B Trimul Estate Nr. Lincoin Pharma Po.: Khatraj Ta. Kalol, Gandhinagar, Gujarat, India – 382721.